Author:
Songprakhon Pucharee,Thaingtamtanha Thanawat,Limjindaporn Thawornchai,Puttikhunt Chunya,Srisawat Chatchawan,Luangaram Prasit,Dechtawewat Thanyaporn,Uthaipibull Chairat,Thongsima Sissades,Yenchitsomanus Pa-thai,Malasit Prida,Noisakran Sansanee
Abstract
AbstractViruses manipulate the life cycle in host cells via the use of viral properties and host machineries. Development of antiviral peptides against dengue virus (DENV) infection has previously been concentrated on blocking the actions of viral structural proteins and enzymes in virus entry and viral RNA processing in host cells. In this study, we proposed DENV NS1, which is a multifunctional non-structural protein indispensable for virus production, as a new target for inhibition of DENV infection by specific peptides. We performed biopanning assays using a phage-displayed peptide library and identified 11 different sequences of 12-mer peptides binding to DENV NS1. In silico analyses of peptide-protein interactions revealed 4 peptides most likely to bind to DENV NS1 at specific positions and their association was analysed by surface plasmon resonance. Treatment of Huh7 cells with these 4 peptides conjugated with N-terminal fluorescent tag and C-terminal cell penetrating tag at varying time-of-addition post-DENV infection could inhibit the production of DENV-2 in a time- and dose-dependent manner. The inhibitory effects of the peptides were also observed in other virus serotypes (DENV-1 and DENV-4), but not in DENV-3. These findings indicate the potential application of peptides targeting DENV NS1 as antiviral agents against DENV infection.
Funder
Chalermphrakiat Grant, Faculty of Medicine Siriraj Hospital, Mahidol University.
Research Chair Grant 2015 from NSTDA
National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency (NSTDA), Thailand
Thailand Research Fund
Publisher
Springer Science and Business Media LLC
Reference86 articles.
1. Bhatt, S. et al. The global distribution and burden of dengue. Nature 496, 504–507 (2013).
2. World Health Organization, https://www.who.int/en/news-room/fact-sheets/detail/dengue-and-severe-dengue. Accessed 15 Feb 2020.
3. Martina, B. E. E., Koraka, P. & Osterhaus, A. D. M. E. Dengue virus pathogenesis: an integrated view. Clin. Microbiol. Rev. 22, 564–581 (2009).
4. Grange, L. et al. Epidemiological risk factors associated with high global frequency of inapparent dengue virus infections. Front. Immunol. 5, 280 (2014).
5. Hadinegoro, S. R. et al. Efficacy and long-term safety of a dengue vaccine in regions of endemic disease. N. Engl. J. Med. 373, 1195–1206 (2015).
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献